Conavi Medical Corp.
CNVIF
$0.26
$0.00461.80%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 40.40K | 3.10M | 352.70K | 293.10K | 436.90K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 40.40K | 3.10M | 352.70K | 293.10K | 436.90K |
| Cost of Revenue | -60.60K | 521.80K | 326.30K | 335.40K | 454.70K |
| Gross Profit | 101.00K | 2.58M | 26.40K | -42.40K | -17.80K |
| SG&A Expenses | 1.06M | 1.16M | 1.32M | 1.66M | 1.13M |
| Depreciation & Amortization | 140.10K | 146.40K | 176.00K | 162.20K | 185.40K |
| Other Operating Expenses | -- | 82.90K | 209.70K | -- | -- |
| Total Operating Expenses | 3.81M | 4.94M | 5.05M | 6.79M | 4.90M |
| Operating Income | -3.77M | -1.84M | -4.70M | -6.50M | -4.46M |
| Income Before Tax | -2.18M | -3.63M | -11.79M | -9.52M | -5.27M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.18M | -3.63M | -11.79M | -9.52M | -5.27M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.18M | -3.63M | -11.79M | -9.52M | -5.27M |
| EBIT | -3.77M | -1.84M | -4.70M | -6.50M | -4.46M |
| EBITDA | -3.68M | -1.75M | -4.59M | -6.38M | -4.31M |
| EPS Basic | -0.05 | -0.09 | -1.91 | -1.55 | -0.86 |
| Normalized Basic EPS | -0.06 | -0.09 | -0.72 | -0.77 | -0.55 |
| EPS Diluted | -0.05 | -0.09 | -1.91 | -1.55 | -0.86 |
| Normalized Diluted EPS | -0.06 | -0.09 | -0.72 | -0.77 | -0.55 |
| Average Basic Shares Outstanding | 44.25M | 42.16M | 6.17M | 6.16M | 6.16M |
| Average Diluted Shares Outstanding | 44.25M | 42.16M | 6.17M | 6.16M | 6.16M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |